Table 3. Correlation between different response and the PFS in patients treated with chemotherapy (n = 30).
| Items | PFS (months) (95% CI) | Univariate analysis P* | Median survival (months) (95% CI) | Univariate analysis P* |
|---|---|---|---|---|
| 1. PR | 5.0(3.0–6.9) | 0.136 | 27.8(-) | 0.588 |
| SD | 6.9(6.3–7.5) | 22.1(8.5–35.8) | ||
| 2.PR + SD | 6.8(4.3–9.3) | <0.001 | 22.1(8.5–35.8) | 0.564 |
| PD | 0.8(-) | 13.3(-) | ||
| 3.SD | 6.9(4.7–9.2) | <0.001 | 22.1(8.5–35.8) | 0.528 |
| PD | 0.8(-) | 13.3(-) | ||
| 4.PR | 5.0(3.4–6.9) | 0.010 | 27.8(-) | 0.690 |
| PD | 0.8(-) | 13.3(-) |
Note:*Log-Rank test.
Abbreviations: CI, Confidence interval; OS, overall survival; PFS, progression free survival; CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease.